Page 6 - Poster Presentations News Today

Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Guest writer David Monagan a US science and medical journalist fires back against recent moves in banning turf fires "an icon of Ireland’s very identity". David Monaghan calls it junk science.

Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug) and emerging Globo H science. TAIPEI, Taiwan, April 7, 2022 /PRNewswire/ -- OBI Pharma

/PRNewswire/ -- OBI Pharma, Inc. (TPEx: 4174) today announced scientific data highlighting the antitumor synergy of OBI-3424 in combination with pembrolizumab...

New Phase II data show evobrutinib sustained low annualized relapse rates (ARRs) and had no new safety signals at 2.5 years the longest follow-up of any Bruton's tyrosine kinase inhibitor in multiple

Press release content from PR Newswire. The AP news staff was not involved in its creation.

The newsletter features stories from the Junior Investigators, the Pilot Project Awardees, the Research Cores, and COBRE collaborators.